The prolonged PFS observed in ES-SCLC patients receiving symptom-directed radiotherapy (16.1 vs. 7.8 months) aligns with preclinical evidence of radiation-induced PD-L1 upregulation and myeloid-derived suppressor cell depletion (25). The gene discussed is CD274; the disease is small cell lung carcinoma.